These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 15795239

  • 1. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.
    Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F.
    J Exp Med; 2005 Apr 04; 201(7):1031-6. PubMed ID: 15795239
    [Abstract] [Full Text] [Related]

  • 2. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ.
    Cytometry B Clin Cytom; 2008 Jul 04; 74(4):211-20. PubMed ID: 18454493
    [Abstract] [Full Text] [Related]

  • 3. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.
    Transpl Immunol; 2009 Mar 04; 20(4):238-42. PubMed ID: 19032982
    [Abstract] [Full Text] [Related]

  • 4. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
    Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, Garcia-Noblejas A, Clari MA, Chilet M, López J, Hernández-Boluda JC, Remigia MJ, Navarro D.
    J Med Virol; 2010 Jul 04; 82(7):1208-15. PubMed ID: 20513086
    [Abstract] [Full Text] [Related]

  • 5. Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.
    López-Oliva MO, Martinez V, Buitrago A, Jiménez C, Rivas B, Escuin F, Santana MJ, Selgas R, Bellón T.
    Transplantation; 2014 Apr 27; 97(8):839-45. PubMed ID: 24345896
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.
    Gallez-Hawkins G, Thao L, Lacey SF, Martinez J, Li X, Franck AE, Lomeli NA, Longmate J, Diamond DJ, Spielberger R, Forman SJ, Zaia JA.
    Biol Blood Marrow Transplant; 2005 Nov 27; 11(11):890-902. PubMed ID: 16275592
    [Abstract] [Full Text] [Related]

  • 7. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA, Sinclair E, Bredt B, Agrillo L, Black D, Epling CL, Carvidi A, Ho T, Bains R, Adler SP.
    J Clin Virol; 2006 Mar 27; 35(3):332-7. PubMed ID: 16387547
    [Abstract] [Full Text] [Related]

  • 8. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J, Schellens IM, van Baarle D.
    Antivir Ther; 2011 Mar 27; 16(4):565-75. PubMed ID: 21685544
    [Abstract] [Full Text] [Related]

  • 9. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group.
    J Infect Dis; 2006 Dec 01; 194(11):1537-46. PubMed ID: 17083038
    [Abstract] [Full Text] [Related]

  • 10. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.
    Haematologica; 2008 Feb 01; 93(2):248-56. PubMed ID: 18245650
    [Abstract] [Full Text] [Related]

  • 11. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
    Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, Maier M, Liebert UG, Niederwieser D, Engelmann E, Heilbronn R, Thiel E, Uharek L.
    Bone Marrow Transplant; 2007 Mar 01; 39(5):293-9. PubMed ID: 17262060
    [Abstract] [Full Text] [Related]

  • 12. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.
    Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, López J, Garcia-Noblejas A, Muñoz-Cobo B, Costa E, Clari MA, Hernández-Boluda JC, Remigia MJ, Navarro D.
    Bone Marrow Transplant; 2011 Nov 01; 46(11):1437-43. PubMed ID: 21243030
    [Abstract] [Full Text] [Related]

  • 13. Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.
    Pipeling MR, John ER, Orens JB, Lechtzin N, McDyer JF.
    J Infect Dis; 2011 Dec 01; 204(11):1663-71. PubMed ID: 22021622
    [Abstract] [Full Text] [Related]

  • 14. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
    Lilleri D, Zelini P, Fornara C, Comolli G, Revello MG, Gerna G.
    Clin Immunol; 2009 Jun 01; 131(3):395-403. PubMed ID: 19268633
    [Abstract] [Full Text] [Related]

  • 15. Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity.
    Na IK, Letsch A, Guerreiro M, Bauer S, Noack I, Geginat J, Reinke P, Loesch M, Kienapfel H, Thiel E, Volk HD, Scheibenbogen C.
    J Immunother; 2009 Jun 01; 32(9):907-13. PubMed ID: 19816191
    [Abstract] [Full Text] [Related]

  • 16. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
    Giménez E, Muñoz-Cobo B, Solano C, Amat P, de la Cámara R, Nieto J, López J, Remigia MJ, Garcia-Noblejas A, Navarro D.
    Transpl Infect Dis; 2015 Jun 01; 17(3):361-70. PubMed ID: 25850900
    [Abstract] [Full Text] [Related]

  • 17. Rapid generation of CMV pp65-specific T cells for immunotherapy.
    Bao L, Sun Q, Lucas KG.
    J Immunother; 2007 Jun 01; 30(5):557-61. PubMed ID: 17589296
    [Abstract] [Full Text] [Related]

  • 18. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Tormo N, Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, López-Aldeguer N, Hernández-Boluda JC, Remigia MJ, Garcia-Noblejas A, Gimeno C, Navarro D.
    Bone Marrow Transplant; 2010 Mar 01; 45(3):543-9. PubMed ID: 19617905
    [Abstract] [Full Text] [Related]

  • 19. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
    Paine A, Oelke M, Tischer S, Heuft HG, Blasczyk R, Eiz-Vesper B.
    J Immunother; 2010 Jan 01; 33(1):60-72. PubMed ID: 19952955
    [Abstract] [Full Text] [Related]

  • 20. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
    Zandvliet ML, van Liempt E, Jedema I, Veltrop-Duits LA, Willemze R, Guchelaar HJ, Falkenburg JH, Meij P.
    Cytotherapy; 2010 Nov 01; 12(7):933-44. PubMed ID: 20078388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.